CN110326051B - 用于识别生物样本中的表达区别要素的方法和分析系统 - Google Patents
用于识别生物样本中的表达区别要素的方法和分析系统 Download PDFInfo
- Publication number
- CN110326051B CN110326051B CN201880015369.6A CN201880015369A CN110326051B CN 110326051 B CN110326051 B CN 110326051B CN 201880015369 A CN201880015369 A CN 201880015369A CN 110326051 B CN110326051 B CN 110326051B
- Authority
- CN
- China
- Prior art keywords
- expression
- matrix
- gene
- genes
- expression matrix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000014509 gene expression Effects 0.000 title claims abstract description 253
- 239000012472 biological sample Substances 0.000 title claims abstract description 79
- 238000000034 method Methods 0.000 title claims abstract description 65
- 238000004458 analytical method Methods 0.000 title claims description 22
- 239000011159 matrix material Substances 0.000 claims description 102
- 108090000623 proteins and genes Proteins 0.000 claims description 94
- 239000013598 vector Substances 0.000 claims description 10
- 238000004891 communication Methods 0.000 claims description 5
- 206010028980 Neoplasm Diseases 0.000 claims description 4
- 230000004186 co-expression Effects 0.000 claims description 4
- 238000012545 processing Methods 0.000 claims description 4
- 230000008859 change Effects 0.000 claims description 3
- 238000005516 engineering process Methods 0.000 abstract description 12
- 206010061818 Disease progression Diseases 0.000 abstract description 4
- 230000027455 binding Effects 0.000 abstract description 4
- 230000005750 disease progression Effects 0.000 abstract description 4
- 230000007246 mechanism Effects 0.000 abstract description 4
- 210000004027 cell Anatomy 0.000 description 73
- 239000000523 sample Substances 0.000 description 29
- 230000031018 biological processes and functions Effects 0.000 description 22
- 239000000203 mixture Substances 0.000 description 15
- 238000010195 expression analysis Methods 0.000 description 14
- 238000003860 storage Methods 0.000 description 8
- 239000000853 adhesive Substances 0.000 description 7
- 230000001070 adhesive effect Effects 0.000 description 7
- 238000005259 measurement Methods 0.000 description 6
- 238000002493 microarray Methods 0.000 description 6
- 239000012634 fragment Substances 0.000 description 5
- 239000003550 marker Substances 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 239000011230 binding agent Substances 0.000 description 4
- 238000004364 calculation method Methods 0.000 description 4
- 230000004069 differentiation Effects 0.000 description 4
- 108091023037 Aptamer Proteins 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 210000003719 b-lymphocyte Anatomy 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 239000013604 expression vector Substances 0.000 description 3
- 230000027291 mitotic cell cycle Effects 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 150000007523 nucleic acids Chemical class 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 241000736262 Microbiota Species 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 230000011712 cell development Effects 0.000 description 2
- 210000001072 colon Anatomy 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 210000003016 hypothalamus Anatomy 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000007481 next generation sequencing Methods 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000002285 radioactive effect Effects 0.000 description 2
- 238000004611 spectroscopical analysis Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000001960 triggered effect Effects 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 101150110188 30 gene Proteins 0.000 description 1
- 101150033839 4 gene Proteins 0.000 description 1
- 101150096316 5 gene Proteins 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 238000003559 RNA-seq method Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000007707 calorimetry Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 238000002659 cell therapy Methods 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000003748 differential diagnosis Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- -1 lectins or sugars) Chemical class 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 108091005601 modified peptides Proteins 0.000 description 1
- 230000009149 molecular binding Effects 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000000513 principal component analysis Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000000275 quality assurance Methods 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 210000002536 stromal cell Anatomy 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
- G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Medical Informatics (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Theoretical Computer Science (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Evolutionary Biology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Pathology (AREA)
- Evolutionary Computation (AREA)
- Public Health (AREA)
- Artificial Intelligence (AREA)
- Bioethics (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Data Mining & Analysis (AREA)
- Databases & Information Systems (AREA)
- Epidemiology (AREA)
- Software Systems (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
Abstract
Description
Claims (15)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762466807P | 2017-03-03 | 2017-03-03 | |
US62/466807 | 2017-03-03 | ||
US15/659359 | 2017-07-25 | ||
US15/659,359 US20180251849A1 (en) | 2017-03-03 | 2017-07-25 | Method for identifying expression distinguishers in biological samples |
PCT/EP2018/055146 WO2018158412A1 (en) | 2017-03-03 | 2018-03-02 | Method for identifying expression distinguishers in biological samples |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110326051A CN110326051A (zh) | 2019-10-11 |
CN110326051B true CN110326051B (zh) | 2023-11-14 |
Family
ID=63357259
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201880015369.6A Active CN110326051B (zh) | 2017-03-03 | 2018-03-02 | 用于识别生物样本中的表达区别要素的方法和分析系统 |
Country Status (4)
Country | Link |
---|---|
US (1) | US20180251849A1 (zh) |
EP (1) | EP3590059B1 (zh) |
CN (1) | CN110326051B (zh) |
WO (1) | WO2018158412A1 (zh) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11348661B2 (en) | 2018-05-14 | 2022-05-31 | Tempus Labs, Inc. | Predicting total nucleic acid yield and dissection boundaries for histology slides |
US10957041B2 (en) | 2018-05-14 | 2021-03-23 | Tempus Labs, Inc. | Determining biomarkers from histopathology slide images |
US11348240B2 (en) | 2018-05-14 | 2022-05-31 | Tempus Labs, Inc. | Predicting total nucleic acid yield and dissection boundaries for histology slides |
EP3794551A4 (en) | 2018-05-14 | 2022-02-09 | Tempus Labs, Inc. | FRAMEWORK FOR GENERALIZABLE AND INTERPRETABLE DEEP LEARNING FOR PREDICTING MSI FROM HISTOPATHOLOGICAL SLIDE IMAGES |
US11348239B2 (en) | 2018-05-14 | 2022-05-31 | Tempus Labs, Inc. | Predicting total nucleic acid yield and dissection boundaries for histology slides |
AU2019417836A1 (en) * | 2018-12-31 | 2021-07-15 | Tempus Ai, Inc. | Transcriptome deconvolution of metastatic tissue samples |
CN114424287A (zh) * | 2019-09-25 | 2022-04-29 | 瑞泽恩制药公司 | 单细胞rna-seq数据处理 |
KR102512932B1 (ko) * | 2020-01-31 | 2023-03-22 | 한국과학기술원 | 암 환자의 발현량 데이터로부터 암세포 내재적 특성을 추출하는 방법 및 이를 위한 장치 |
Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101965190A (zh) * | 2005-04-04 | 2011-02-02 | 维里德克斯有限责任公司 | 乳腺肿瘤的激光显微解剖和微阵列分析揭示雌激素受体相关的基因和途径 |
CN102864219A (zh) * | 2011-07-05 | 2013-01-09 | 中国人民解放军军事医学科学院放射与辐射医学研究所 | 一种用多重pcr矩阵法进行高通量基因表达谱检测的方法 |
CN102918165A (zh) * | 2010-03-24 | 2013-02-06 | Tc园表达公司 | 患有炎症疾病的受试者对细胞因子靶向药物(CyTD)的早期反应或无反应预测的基因和基因组合 |
CN102985927A (zh) * | 2010-04-29 | 2013-03-20 | 加利福尼亚大学董事会 | 利用关于基因组模型的数据集成的途径识别算法(paradigm) |
CN103164631A (zh) * | 2013-04-16 | 2013-06-19 | 东华大学 | 一种智能协同表达基因分析仪 |
CN103168118A (zh) * | 2010-04-06 | 2013-06-19 | 麻省理工学院 | 用减少数量的转录物测量进行的基因表达概况分析 |
CN103268431A (zh) * | 2013-05-21 | 2013-08-28 | 中山大学 | 一种基于学生t分布的癌症亚型生物标志物检测系统 |
CN103745137A (zh) * | 2014-01-30 | 2014-04-23 | 思博奥科生物信息科技(北京)有限公司 | 一种跨芯片平台的基因表达数据整合方法 |
CN104011726A (zh) * | 2011-10-26 | 2014-08-27 | 加利福尼亚大学董事会 | 利用关于基因组模型的数据集成的途径识别算法(paradigm) |
CN104106072A (zh) * | 2011-12-08 | 2014-10-15 | 皇家飞利浦有限公司 | 使用全基因组序列的生物细胞评估以及使用所述全基因组序列的肿瘤学治疗规划 |
CN104662173A (zh) * | 2012-07-26 | 2015-05-27 | 加利福尼亚大学董事会 | 自闭症和其它发育障碍的筛查、诊断和预后 |
CN104704499A (zh) * | 2012-06-21 | 2015-06-10 | 菲利普莫里斯生产公司 | 与基于网络的生物标记签名相关的系统和方法 |
CN105740653A (zh) * | 2016-01-27 | 2016-07-06 | 北京工业大学 | 基于LLRFC和相关性分析去除冗余的特征选择方法LLRFC score+ |
CN106295246A (zh) * | 2016-08-07 | 2017-01-04 | 吉林大学 | 找到与肿瘤相关的lncRNA并预测其功能 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040063652A1 (en) * | 1988-03-21 | 2004-04-01 | Jolly Douglas J. | Combination gene delivery vehicles |
AU2001234805A1 (en) * | 2000-02-04 | 2001-08-14 | University Of South Florida | Statistical analysis method for classifying objects |
US20050240357A1 (en) * | 2004-04-26 | 2005-10-27 | Minor James M | Methods and systems for differential clustering |
US8455626B2 (en) * | 2006-11-30 | 2013-06-04 | Abbott Laboratories | Aβ conformer selective anti-aβ globulomer monoclonal antibodies |
-
2017
- 2017-07-25 US US15/659,359 patent/US20180251849A1/en active Pending
-
2018
- 2018-03-02 CN CN201880015369.6A patent/CN110326051B/zh active Active
- 2018-03-02 WO PCT/EP2018/055146 patent/WO2018158412A1/en active Application Filing
- 2018-03-02 EP EP18708976.8A patent/EP3590059B1/en active Active
Patent Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101965190A (zh) * | 2005-04-04 | 2011-02-02 | 维里德克斯有限责任公司 | 乳腺肿瘤的激光显微解剖和微阵列分析揭示雌激素受体相关的基因和途径 |
CN102918165A (zh) * | 2010-03-24 | 2013-02-06 | Tc园表达公司 | 患有炎症疾病的受试者对细胞因子靶向药物(CyTD)的早期反应或无反应预测的基因和基因组合 |
CN103168118A (zh) * | 2010-04-06 | 2013-06-19 | 麻省理工学院 | 用减少数量的转录物测量进行的基因表达概况分析 |
CN102985927A (zh) * | 2010-04-29 | 2013-03-20 | 加利福尼亚大学董事会 | 利用关于基因组模型的数据集成的途径识别算法(paradigm) |
CN102864219A (zh) * | 2011-07-05 | 2013-01-09 | 中国人民解放军军事医学科学院放射与辐射医学研究所 | 一种用多重pcr矩阵法进行高通量基因表达谱检测的方法 |
CN104011726A (zh) * | 2011-10-26 | 2014-08-27 | 加利福尼亚大学董事会 | 利用关于基因组模型的数据集成的途径识别算法(paradigm) |
CN104106072A (zh) * | 2011-12-08 | 2014-10-15 | 皇家飞利浦有限公司 | 使用全基因组序列的生物细胞评估以及使用所述全基因组序列的肿瘤学治疗规划 |
CN104704499A (zh) * | 2012-06-21 | 2015-06-10 | 菲利普莫里斯生产公司 | 与基于网络的生物标记签名相关的系统和方法 |
CN104662173A (zh) * | 2012-07-26 | 2015-05-27 | 加利福尼亚大学董事会 | 自闭症和其它发育障碍的筛查、诊断和预后 |
CN103164631A (zh) * | 2013-04-16 | 2013-06-19 | 东华大学 | 一种智能协同表达基因分析仪 |
CN103268431A (zh) * | 2013-05-21 | 2013-08-28 | 中山大学 | 一种基于学生t分布的癌症亚型生物标志物检测系统 |
CN103745137A (zh) * | 2014-01-30 | 2014-04-23 | 思博奥科生物信息科技(北京)有限公司 | 一种跨芯片平台的基因表达数据整合方法 |
CN105740653A (zh) * | 2016-01-27 | 2016-07-06 | 北京工业大学 | 基于LLRFC和相关性分析去除冗余的特征选择方法LLRFC score+ |
CN106295246A (zh) * | 2016-08-07 | 2017-01-04 | 吉林大学 | 找到与肿瘤相关的lncRNA并预测其功能 |
Non-Patent Citations (6)
Title |
---|
Minghao Sun 等.Characterizing the microstructures of biological tissues using Mueller matrix and transformed polarization parameters.《Biomed Opt Express》.2014,4223–4234. * |
Niya Wang 等.Mathematical modelling of transcriptional heterogeneity identifies novel markers and subpopulations in complex tissues.《Scientific Reports》.2016,全文. * |
Sanjeev Arora 等.A Practical Algorithm for Topic Modeling with Provable Guarantees.《arXiv:1212.4777》.2012,1-26. * |
杨丽.基于样本加权的特征基因选择方法研究.《中国优秀硕士学位论文全文数据库 信息科技辑》.2014,I138-1167. * |
欧阳玉梅.酵母蛋白质相互作用与基因表达谱和亚细胞定位的相关性.《中国生物化学与分子生物学报》.2008,950-956. * |
黄克非.通过共表达网络分析(WGCNA)研究前列腺癌症中的特异表达因子.《中国优秀硕士学位论文全文数据库 医药卫生科技辑》.2015,E072-802. * |
Also Published As
Publication number | Publication date |
---|---|
WO2018158412A1 (en) | 2018-09-07 |
US20180251849A1 (en) | 2018-09-06 |
CN110326051A (zh) | 2019-10-11 |
EP3590059B1 (en) | 2023-09-13 |
EP3590059A1 (en) | 2020-01-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110326051B (zh) | 用于识别生物样本中的表达区别要素的方法和分析系统 | |
He et al. | High-plex imaging of RNA and proteins at subcellular resolution in fixed tissue by spatial molecular imaging | |
Su et al. | Single cell proteomics in biomedicine: High‐dimensional data acquisition, visualization, and analysis | |
JP7057913B2 (ja) | ビッグデータ解析方法及び該解析方法を利用した質量分析システム | |
Hamadeh et al. | An overview of toxicogenomics | |
JP5464503B2 (ja) | 医療分析システム | |
US9996924B2 (en) | Systems and methods for spectral unmixing of microscopic images using pixel grouping | |
Röst et al. | Reproducible quantitative proteotype data matrices for systems biology | |
McDonnell et al. | Mass spectrometry image correlation: quantifying colocalization | |
Klyuchko | On the mathematical methods in biology and medicine | |
Partel et al. | Automated identification of the mouse brain’s spatial compartments from in situ sequencing data | |
Woloshuk et al. | In situ classification of cell types in human kidney tissue using 3D nuclear staining | |
US20090319450A1 (en) | Protein search method and device | |
Wrobel et al. | Statistical analysis of multiplex immunofluorescence and immunohistochemistry imaging data | |
Mignardi et al. | Bridging histology and bioinformatics—computational analysis of spatially resolved transcriptomics | |
Cleary et al. | Compressed sensing for imaging transcriptomics | |
Zhao et al. | Multiplex imaging in immuno-oncology | |
Kondo et al. | Application of 2D-DIGE in cancer proteomics toward personalized medicine | |
US20140372450A1 (en) | Methods of viewing and analyzing high content biological data | |
Ben-Uri et al. | Escalating high-dimensional imaging using combinatorial channel multiplexing and deep learning | |
Nambiar et al. | Global gene expression profiling: a complement to conventional histopathologic analysis of neoplasia | |
Gao et al. | A review of recent advances in spatially resolved transcriptomics data analysis | |
Valihrach et al. | A practical guide to spatial transcriptomics | |
CN113718032B (zh) | 生物标志物在早期检测宫颈癌中的应用 | |
CN117672343B (zh) | 测序饱和度评估方法及装置、设备及存储介质 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20210826 Address after: England Applicant after: Global life science solutions UK Ltd. Address before: Buckinghamshire Applicant before: GE HEALTHCARE UK Ltd. Effective date of registration: 20210826 Address after: Buckinghamshire Applicant after: GE HEALTHCARE UK Ltd. Address before: New York State, USA Applicant before: General Electric Co. |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TG01 | Patent term adjustment |